Gli altri portali
Notizie
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
Midea Demonstrates Comprehensive Sustainable HVAC Lineup at C&R 2025 in Madrid
Backed by a research force of over 10,000 engineers and 42 pilot laboratories, Midea has developed a full-spectrum R290 product matrix. These offerings span residential, commercial, and industrial applications, reflecting the company's strategic vision of making green technology scalable and accessible. Backed by a research force of over 10,000 engineers and 42 pilot laboratories, Midea has developed a full-spectrum R290 product matrix. These offerings span residential, commercial, and...
PR Newswire
21/11/2025
Meril Life Sciences Presents One-year Outcomes from the LANDMARK Randomized…
The trial also assessed an extended clinical efficacy endpoint (Freedom from all-cause mortality, all stroke, procedure- or valve-related hospitalization and QOL deterioration) reflecting sustained clinical benefit over time. These extended outcomes remained consistent across platforms, measured at 80.5% for Myval THV Series, 75.0% for Sapien THV Series, and 79.7% for Evolut THV Series. Importantly, the Myval THV series demonstrated the lowest incidence of moderate aortic regurgitation, recorded…
PR Newswire
21/11/2025
Trading by management and close relations of management
Please read the full announcement in PDF Attachment 2025_49_Trading_By_Management
Nasdaq GlobeNewswire
21/11/2025
IEI Secures TFDA QMS Approval and ISO 13485 Certification, Reinforcing…
Backed by TFDA Class II credentials, IEI is prioritizing CDMO partnerships in medical imaging peripherals, vital-sign monitoring, and endoscopy/OR integration—bringing compliant designs to clinical use faster. Backed by TFDA Class II credentials, IEI is prioritizing CDMO partnerships in medical imaging peripherals, vital-sign monitoring, and endoscopy/OR integration—bringing compliant designs to clinical use faster. IEI's Qidu (Chi-Du) campus delivers 38K PCBA units per month and38K...
PR Newswire
21/11/2025
DermRays Launches Care+, a New Enhanced Protection Program for At-Home Laser…
DermRays Care+: Total Protection for Your Device DermRays Care+: Total Protection for Your Device Extended Hardware Warranty - Adds an additional 1-year product warranty beyond the standard coverage. Accidental Damage Protection - Covers up to 2 accidental damage incidents, including drops or liquid exposure, throughout the warranty period. Accessory Coverage - Protects original in-box accessories against manufacturing defects. Priority Support Access - Provides direct access to...
PR Newswire
21/11/2025
Kanazawa University research: Scientists develop a new method to measure…
Experimental Approach Experimental Approach The team led bySatoshi Araidesigned qMaLioffG by carefully engineering a fluorescent protein that behaves differently depending on how much ATP is present (Figure 1). When ATP binds to this protein, the duration of its glow—known as fluorescence lifetime—changes in a measurable way. Unlike brightness, which can be influenced by microscope settings, protein concentration, or cell shape, fluorescence lifetime is unaffected by experimental...
PR Newswire
21/11/2025
Colebrook Bosson Saunders Launches Their First Sustainability Report
Amalie Aarestrup, Sustainability Lead, Colebrook Bosson Saunders, commented: "We [under MillerKnoll] are united by the same sustainability mission, yet each brand brings its own priorities and solutions. We're excited for the road ahead — harnessing innovation to keep moving toward a future of positive change." Amalie Aarestrup, Sustainability Lead, Colebrook Bosson Saunders, commented: "We [under MillerKnoll] are united by the same sustainability mission, yet each brand brings…
PR Newswire
21/11/2025
Alcohol Use Disorder Market to Grow Rapidly at a 13.6% CAGR by 2034 Owing to…
Alcohol Use Disorder Market Summary Alcohol Use Disorder Market Summary Discover the new alcohol use disorder treatment @Alcohol Use Disorder Treatment Market Key Factors Driving the Growth of the Alcohol Use Disorder Market Rising Prevalence of Alcohol Use Disorder Increasing rates of alcohol consumption worldwide, coupled with lifestyle changes and stress-related factors, have led to a growing number of individuals diagnosed with AUD. The 12-month diagnosed prevalent...
PR Newswire
20/11/2025
Information on the total number of voting rights and shares
REGULATED INFORMATIONInformation on the total number of voting rights and sharesMont-Saint-Guibert(Belgium), November 20, 2025 , 10:30 pm CET / 4:30 pm ET –In accordance with article 15 of the Law of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels and Nasdaq: NYXH) publishes the below information following the issue of new shares. Share capital: EUR 6.504.688,76 Total number of securities carrying voting rights: 43,026,460 (all ordinary...
Nasdaq GlobeNewswire
20/11/2025
Innocan Pharma announces promising results of LPT-CBD administered to Gottingen…
In the study, three rabbits and three Göttingen minipigs were administered a single injection of LPT-CBD at ascending doses. The animals were then evaluated for pharmacokinetics and preliminary safety parameters for a period of 10 days in rabbits and 28 days in minipigs. Key findings include: In the study, three rabbits and three Göttingen minipigs were administered a single injection of LPT-CBD at ascending doses. The animals were then evaluated for pharmacokinetics and preliminary safety...
PR Newswire
20/11/2025
Grant of Restricted Stock Units and Warrants to Employees in Genmab
Company AnnouncementCOPENHAGEN, Denmark; November 20, 2025 –Genmab A/S(Nasdaq: GMAB) announced today that the Board of Directors decided to grant 6,933 restricted stock units and 7,377 warrants to employees of the Company and the Company's subsidiaries. Each restricted stock unit is awarded cost-free and provides the owner with a conditional right to receive one share in Genmab A/S of nominally DKK 1. The fair value of each restricted stock unit is equal to the closing market...
Nasdaq GlobeNewswire
20/11/2025
Northwest Biotherapeutics Announces That Construction Activities Are Under Way…
When a medical product is able to be manufactured using closed equipment and procedures that are not open to the air, the manufacturing can be conducted in Grade C manufacturing suites which are much less onerous and expensive to operate. In addition, multiple or numerous patient products may be manufactured simultaneously in a single Grade C manufacturing, and only certain equipment (not the whole suite) must be cleaned between production batches. These differences can enable a major increase…
PR Newswire
20/11/2025
GENFIT Reports Third Quarter 2025 Financial Information and Provides a Corporate…
Cash and cash equivalents totaled €119.0 million as of September 30, 2025€39.2 million in revenues for the nine months ended September 30, 2025, including the €26.5 million milestone payment following pricing and reimbursement approval of Iqirvo ®(elafibranor) in three major European markets Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), November 20, 2025-GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving...
Nasdaq GlobeNewswire
20/11/2025
Oxurion Receives Transparency Notification from Atlas Special Opportunities II…
Leuven, BELGIUM – November 20, 2025 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received a transparency notification as follows: Oxurion received a transparency notification on November 20, 2025, from Atlas Special Opportunities…
Actusnews Wire
20/11/2025
SEQUANA MEDICAL ANNOUNCES THE ISSUANCE OF A SUBSCRIPTION REQUEST NOTICE UNDER…
SEQUANA MEDICAL ANNOUNCES THE ISSUANCE OF A SUBSCRIPTION REQUEST NOTICE UNDER THE SHARE SUBSCRIPTION FACILITY AGREEMENT WITH GEMPRESS RELEASE REGULATED INFORMATION – INSIDE INFORMATION 20 November 2025, 6:00 pm CETGhent, Belgium, 20 November 2025 – Sequana Medical NV(Euronext Brussels: SEQUA)(the " Company " or " SequanaMedical "), a pioneer in the treatment of drug-resistant fluid overload in liver disease, heart failure and cancer, announces today that it issued a...
Nasdaq GlobeNewswire
20/11/2025
GENFIT announces effectiveness of voluntary delisting of American Depositary…
Lille (France), Cambridge (Massachusetts, United States), (Zurich, Switzerland); November 20, 2025 – GENFIT (Nasdaq and Euronext: GNFT),a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announces that the Company’s voluntary delisting of American Depositary Shares (“ADSs”) representing its ordinary shares from The Nasdaq Global Select Market (“Nasdaq”) has become effective. Each ADS represents one ordinary share of...
Nasdaq GlobeNewswire
20/11/2025
Radiology AI Market worth $2.27 billion by 2030 with 24.5% CAGR |…
Browse in-depth TOC on "Radiology AI Market" Browse in-depth TOC on "Radiology AI Market" 150 - Tables50 - Figures 450 - Pages By indication,the radiology AI market is segmented into oncology, cardiology, neurology, pulmonology/respiratory diseases, orthopedics, women's health, and other indications. The oncology segment is expected to register the highest CAGR in the radiology AI market, driven by the rapidly increasing global cancer burden and the significant...
PR Newswire
20/11/2025
PeproMene Bio's PMB-CT01 BAFFR-CAR T Data Selected for Two Oral Presentations at…
r/r B-NHL r/r B-NHL Safety:PMB-CT01 demonstrated an exceptionally favorable tolerability profile. No Grade ˃1 Cytokine Release Syndrome (CRS) and no Grade ˃1 Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) Efficacy:All the first 7 patients achieved a Complete Response (CR) at 1–3 months post-infusion, including those previously treated with CD19 CAR T therapy and those with CD19-negative disease. Durability:Remissions have remained ongoing for up to 32+...
PR Newswire
20/11/2025
Genomics Market worth $85.09 billion by 2030 with 12.6% CAGR |…
Browse in-depth TOC on "Genomics Market" Browse in-depth TOC on "Genomics Market" 350 - Tables 50 - Figures 310 - Pages By offerings,the genomics market is segmented into products and services. The products segment accounted for the largest share of the genomics market in 2024. The large share of the products segment can be attributed to innovations in genomics technology, such as long-read sequencing (LRS), single-cell genomics, and CRISPR technology, which have expanded...
PR Newswire
20/11/2025
Waterdrop Filter Launches Black Friday, Cyber Monday Sale with Discounts Across…
The Waterdrop Filter K6 Reverse Osmosis System, discounted to $499 from $799, is the first tankless RO system with instant hot water. Recognized by major media as one of 2024's best under-sink systems, it offers a 600G flow rate, five-stage filtration, and built-in safety features, including heating overtime protection. Ideal for families with infants or seniors, the K6 provides instant hot or cold water while preventing limescale buildup. The Waterdrop Filter K6 Reverse Osmosis System ,...
PR Newswire
20/11/2025
Oxford-Harrington Rare Disease Centre Announces 2025 Scholars Advancing…
Rare diseases affect an estimated 500 million people worldwide—half of whom are children. Yet, fewer than 5% of the 7,000 known rare diseases have approved treatments. The OHC, a unique partnership between the University of Oxford, UK and Harrington Discovery Institute at University Hospitals, Cleveland, Ohio, is on a mission to accelerate progress by combining philanthropy, world-class science and entrepreneurial drug development. Rare diseases affect an estimated 500 million people...
PR Newswire
20/11/2025
From Inspiration to Reality: The LEPAS Design Team Decodes the Birth of "Leopard…
Interior Design: Serenity and Comfort Under the 'Skyline'The interior represents the essence of elegance and the spirit of "Leopard Aesthetics." Inspired by a tranquil Skyline, the wrap-around cockpit isolates urban noise and sets a calming atmosphere. The central Waterfall Screen flows like natural currents, extending smooth visual lines. A soft, wave-textured instrument panel feels warm and soothing, while pebble-patterned speaker grilles and floating stone accents pair with ambient…
PR Newswire
20/11/2025
ViVac Appoints Keren Leshem as Chief Executive Officer, Strengthening Leadership…
Leshem, a World Economic Forum Technology Pioneer CEO, has been recognized by Forbes and Entrepreneur as one of the most influential leaders. She brings almost three decades of experience leading clinical-stage life science companies and translating breakthrough research into commercial success. Leshem, aWorld Economic Forum Technology Pioneer CEO, has been recognized byForbesandEntrepreneuras one of the most influential leaders. She brings almost three decades of experience leading...
PR Newswire
20/11/2025
HitGen Receives New Funding to Discover Novel Therapeutics for Underserved…
"We are honored to continue this important work with support from the Gates Foundation," said Dr. Jin Li, Chairman of the Board and Chief Executive Officer of HitGen Inc. "We look forward to engaging with other world-leading philanthropic and academic institutions to deliver transformative solutions for patients with unmet medical needs." "We are honored to continue this important work with support from the Gates Foundation," saidDr.Jin Li, Chairman of the Board and…
PR Newswire
20/11/2025
Altri Comunicati